Zobrazeno 1 - 10
of 311
pro vyhledávání: '"Tasken KA"'
Autor:
Erickson A, Carlos S. Moreno, Michelle M. Kouspou, Fred Saad, Michael S. Lewis, Onur Ertunc, Adeboye O. Osunkoya, Colm Morrissey, Bigler Sa, Tuomas Mirtti, Anne-Marie Mes-Masson, Stephen J. Freedland, Zhou X, Igor Vidal, Aud Svindland, Larry True, Tracy Jones, Ouellet, Mark Buzza, Wiley K, Tasken Ka, Pekka Taimen, Isla P. Garraway, Ariel H Achtman, Bova Sg, Angelo M. De Marzo, Bruce J. Trock, Dominique Trudel, Berge, Tarja Lamminen, Beatrice S. Knudsen
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:715-727
Background: The need to better understand the molecular underpinnings of the heterogeneous outcomes of patients with prostate cancer is a pressing global problem and a key research priority for Movember. To address this, the Movember Global Action Pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d449ca338368c75c7ed105bf4402ef
https://doi.org/10.1158/1055-9965.epi-21-0600
https://doi.org/10.1158/1055-9965.epi-21-0600
Autor:
Ouellet V; Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Canada., Erickson A; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.; Department of Pathology, Helsinki and Uusimaa Hospital District and Medicum, University of Helsinki, Helsinki, Finland.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Wiley K; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Morrissey C; Department of Urology, University of Washington, Seattle, Washington., Berge V; Department of Urology, Oslo University Hospital, Oslo, Norway., Moreno CS; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute of Emory University, Atlanta, Georgia., Tasken KA; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Trudel D; Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Canada.; Department of Pathology and Cellular Biology, Université de Montréal, Montreal, Canada., True LD; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington., Lewis MS; West Los Angeles Veterans Affairs Medical Center and Departments of Pathology and Medicine, Cedars-Sinai Medical Center, Los Angeles, California., Svindland A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Ertunc O; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Suleyman Demirel University, Department of Pathology, Training and Research Hospital East Campus, Isparta, Turkey., Vidal ID; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Osunkoya AO; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia.; Winship Cancer Institute of Emory University, Atlanta, Georgia., Jones T; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Bova GS; Faculty of Medicine and Health Technology, Prostate Cancer Research Center, Tampere University and Tays Cancer Center, Tampere, Finland., Lamminen T; Institute of Biomedicine, University of Turku, Turku, Finland., Achtman AH; Movember, Melbourne, Australia., Buzza M; Movember, Melbourne, Australia., Kouspou MM; Movember, Melbourne, Australia., Bigler SA; Department of Pathology, Mississippi Baptist Medical Center, Jackson, Mississippi., Zhou X; Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi., Freedland SJ; Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Los Angeles, California.; Section of Urology, Durham VA Medical Center, Durham, North Carolina., Mes-Masson AM; Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Canada.; Department of Medicine, Université de Montréal, Montreal, Canada., Garraway IP; Department of Urology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, California.; Division of Urology, Greater Los Angeles VA Healthcare System, Los Angeles, California., Trock BJ; Department of Urology and Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland., Taimen P; Institute of Biomedicine, University of Turku, Turku, Finland.; Department of Pathology, Turku University Hospital, Turku, Finland., Saad F; Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Canada.; Department of Surgery, Université de Montréal, Montreal, Canada., Mirtti T; HUS Diagnostic Center, Department of Pathology, HUS Helsinki University Hospital, Helsinki, Finland.; Medicum and Research Program In Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Knudsen BS; Digital and Computational Pathology, University of Utah, Salt Lake City, Utah., De Marzo AM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Urology and Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2022 Apr 01; Vol. 31 (4), pp. 715-727.
Autor:
Ramirez-Garrastacho M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Bajo-Santos C; Latvian Biomedical Research and Study Centre, Riga, Latvia., Line A; Latvian Biomedical Research and Study Centre, Riga, Latvia., Martens-Uzunova ES; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Urology, Laboratory of Experimental Urology, Erasmus MC, Rotterdam, The Netherlands., de la Fuente JM; Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain., Moros M; Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Zaragoza, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain., Soekmadji C; Department of Cell and Molecular Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.; School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia., Tasken KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Llorente A; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. Alicia.Martinez.Llorente@rr-research.no.; Department for Mechanical, Electronics and Chemical Engineering, Oslo Metropolitan University, Oslo, Norway. Alicia.Martinez.Llorente@rr-research.no.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Feb; Vol. 126 (3), pp. 331-350. Date of Electronic Publication: 2021 Nov 22.
Autor:
Ali S; Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, SC711 Sparks Center, 1720 2nd Avenue South, Birmingham, AL, USA., Dwivedi Y; Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, SC711 Sparks Center, 1720 2nd Avenue South, Birmingham, AL, USA. yogeshdwivedi@uabmc.edu.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.
Autor:
Nyakas M; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aamdal E; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jacobsen KD; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Aamdal S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Brunsvig P; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Tasken KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway.; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway., Maelandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2019 Jul; Vol. 197 (1), pp. 74-82. Date of Electronic Publication: 2019 Mar 21.
Autor:
Prencipe M; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland., Fabre A; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.; Department of Pathology, St Vincent's University Hospital, Dublin, Ireland.; Research Pathology Core, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland., Murphy TB; UCD School of Mathematics and Statistics, Dublin, Ireland., Vargyas E; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.; UCD School of Mathematics and Statistics, Dublin, Ireland., O'Neill A; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden., Tasken KA; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Grytli HH; Institute of Cancer Research, Oslo University Hospital, Oslo, Norway., Svindland A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Berge V; Department of Urology, Oslo University Hospital, Oslo, Norway., Eri LM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Urology, Oslo University Hospital, Oslo, Norway., Gallagher W; OncoMark Limited, NovaUCD, Belfield Innovation Park, Belfield, Dublin, Ireland.; UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland., Watson RW; UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland.
Publikováno v:
The Prostate [Prostate] 2018 Jul; Vol. 78 (10), pp. 724-730. Date of Electronic Publication: 2018 Apr 02.
Autor:
Chen, Lulu1,2 (AUTHOR), Huang, Shuting3 (AUTHOR), Wu, Xiaoxue1 (AUTHOR), He, Weiling1,4 (AUTHOR) hewling@mail.sysu.edu.cn, Song, Mei2 (AUTHOR) songm7@mail.sysu.edu.cn
Publikováno v:
Clinical & Translational Medicine. Jul2024, Vol. 14 Issue 7, p1-26. 26p.
Autor:
Guo, Siyin1 (AUTHOR), Huang, Jing1 (AUTHOR), Li, Genpeng1 (AUTHOR), Chen, Wenjie1 (AUTHOR), Li, Zhihui1 (AUTHOR), Lei, Jianyong1 (AUTHOR) leijianyong@scu.edu.cn
Publikováno v:
Molecular Cancer. 11/30/2023, p1-18. 18p.
Autor:
Lehrer, Steven, Rheinstein, Peter H.
Publikováno v:
American Journal of Clinical Oncology; Dec2024, Vol. 47 Issue 12, p591-594, 4p
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1.
Autor:
Zahalka, Ali H., Fram, Ethan, Garden, Evan, Howard, Lauren, Wiggins, Emily, Babar, Mustufa, Annam, Jay, Reagan, Allison, Eilender, Benjamin, de Hoedt, Amanda, Freedland, Stephen J., Tewari, Ash, Watts, Kara L.
Publikováno v:
BJUI Compass; Nov2024, Vol. 5 Issue 11, p1095-1100, 6p